Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 4, n° 5
pages 544-546 (mai 1981)
Doi : 10.1016/S0190-9622(81)70054-9
Clinical and laboratory study

Pityriasis rosea : Viral complement fixation studies
 

Larry D. Hudson, M.D. , 1, Samuel Adelman, M.D. 1, Charles W. Lewis, M.D. 1
Fort Sam Houston, TX, USA 

Reprint requests to: Dr. Larry D. Hudson, Department of the Army, Dermatology Service, Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX 78234.
@@#100979@@

Eleven patients were seen for pityriasis rosea and underwent acute and convalescent viral complement fixation tests for several respiratory viruses and Mycoplasma . Several patients (6/11) gave a history of antecedent upper respiratory illness; however, no significant rise in titer was seen on any of the complement fixation tests.

The full text of this article is available in PDF format.

* The opinions expressed herein are those of the author and are not necessarily those of the U.S. Army.

1  From the Dermatology Service, Department of Medicine, Brooke Army Medical Center.

Top of the page

© 1981  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@